| Joensuu H, Bono P, Kataja V, et al.
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Eiermann W, Graf E, Ataseven B, et al.
Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) - The German Adjuvant Breast Cancer Group. [JOURNAL ARTICLE]
Eur J Cancer 2009 Oct 29.
Abstract | Full Citation | Find Related Articles | | Avilés A, Nambo MJ, Cleto S, et al.
Rituximab and Dose-Dense Chemotherapy in Primary Testicular Lymphoma. [JOURNAL ARTICLE]
Clin Lymphoma Myeloma 2009 Oct 1; 9(5):386-389.
Abstract | Full Citation | | Ohtsubo K, Watanabe H, Tsuchiyama T, et al.
Advanced hepatocellular carcinoma treated effectively with irinotecan via hepatic arterial infusion followed by proton beam therapy. [Journal Article]
J Infect Chemother 2009 Oct; 15(5):316-21.
Abstract | Full Citation | Find Related Articles | | Jinno H, Sakata M, Hayashida T, et al.
A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer. [JOURNAL ARTICLE]
Ann Oncol 2009 Oct 23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Huang O, Chen C, Wu J, et al.
Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months. [JOURNAL ARTICLE]
BMC Cancer 2009 Oct 21; 9(1):375.
Abstract | Full Citation | Find Related Articles | | Spallarossa P, Altieri P, Pronzato P, et al.
Sub-lethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low pro-senescent doses of epirubicin: the protective role of dexrazoxane. [JOURNAL ARTICLE]
J Pharmacol Exp Ther 2009 Oct 19.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Addeo R, Caraglia M, Bellini S, et al.
Randomized Phase III Trial on Gemcitabine Versus Mytomicin in Recurrent Superficial Bladder Cancer: Evaluation of Efficacy and Tolerance. [JOURNAL ARTICLE]
J Clin Oncol 2009 Oct 19.
Abstract | Full Citation | Find Related Articles | | Kitada N, Nishino M, Yasuda J, et al.
[Equalization of Breast Cancer Chemotherapy at General Hospital( II )-Evaluation of Safety in FEC and TC Regimens-] [English Abstract, Journal Article]
Gan To Kagaku Ryoho 2009 Oct; 36(10):1671-5.
Abstract | Full Citation | Find Related Articles | | Maudens KE, Stove CP, Cocquyt VF, et al.
Development and validation of a liquid chromatographic method for the simultaneous determination of four anthracyclines and their respective 13-S-dihydro metabolites in plasma and saliva. [JOURNAL ARTICLE]
J Chromatogr B Analyt Technol Biomed Life Sci 2009 Oct 2.
Abstract | Full Citation | Publisher Full Text |    |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
